DepMap: siRNA and CRSIPR discrepancy

Question

[Shicheng Guo]

Subject: Insight Requested: Divergent Outcomes Between siRNA and CRISPR Technologies in POLD1 Investigation via DepMap

Dear Community,

I am currently engaged in a thorough analysis of gene function alterations, specifically focusing on the gene POLD1, utilizing data extracted from the Dependency Map (DepMap) portal. In the course of my investigation, I have encountered a perplexing discrepancy between the outcomes derived from small interfering RNA (siRNA) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technologies. This divergence has piqued my curiosity, and I am keen to delve deeper into understanding the underlying reasons for these differing results.

siRNA, as a method, facilitates gene silencing through the targeted degradation of mRNA, thus reducing protein synthesis without directly altering the DNA. On the other hand, CRISPR-Cas9 technology offers a more direct approach by introducing specific mutations into the DNA, potentially leading to complete gene knockout. Both methods are pivotal for functional genomics studies, yet their outcomes, as observed in the context of POLD1 in the DepMap database, do not fully align.

This discrepancy raises several intriguing questions: Does the difference in outcomes highlight a fundamental aspect of POLD1's biology that we are yet to understand? Could the varying efficiencies of these technologies in different cellular contexts play a role in this discrepancy? Or might it hint at off-target effects or other technical nuances associated with either siRNA or CRISPR methodologies?

Given the complexity of this issue, I am reaching out to the wider research community for insights, interpretations, or any similar experiences you might be willing to share regarding the use of siRNA and CRISPR technologies in gene function studies, particularly concerning POLD1. Any theoretical or practical perspectives that could shed light on this matter would be greatly appreciated.

Thank you for your time and for any contributions you might have towards resolving this puzzle.

Best,

[Pierre Lindenbaum]

Dear Community,

again

Don't forget to follow up on your threads. If an answer was helpful, you should upvote it; if the answer resolved your question, you should mark it as accepted. You can accept more than one answer if they all work. If an answer was not really helpful or did not work, provide detailed feedback so others know not to use that answer.

• Uniprotkb's Disease & Variants section out-of-date
• R/python script to extract Subcellular locations (Compartments) from Genecards?
• Tissue specific mRNA expression dataset in human and mouse
• Mathematical/Statistical models to predict mRNA half-life
• Receptors with internalization capability
• rsq Filter in Michigan imputation Server
• fastq-dump split-spot and skip-technical
• Awk in Bioinformatics
• Gallery: Computational tools for DNA methylation
• Server Vendors to provide bioinformatics talents
• "moving average" function for "coverage" signal in bed files?
• eagle2 + minimac4 script for phasing and imputation
• How to understand Structural Variation in bedpe format?
• Genetic variation calling (SNPs) from bulk RNA-seq dataset
• Consensus genotype of MUTECT1, MUTECT2, Varscan, Muse and Somaticsniper
• How to download GTEx figure from USCS genome browser
• Human tissue expression dataset except GTEx
• How to download dbSNP153 vcf files in hg19/GRCH37 version
• ChEMBL ID to Ensembl ID
• eQTL Catalogue Browser: limitation
• Apply beagle5.0 to make imputation and phasing under CentOS and PBS
• Phenotype Enrichment Analysis vs Gene Enrichment Analysis
• Instrumental Variables and confounder in Mendelian Randomization
• Formula of LOEUF: loss-of-function observed/expected upper bound fraction
• Individual-level data for Million Veteran Program (MVP)
• EGAD00010001497 vs EGAD00010001474
• ICD10, main ICD10 and secondary ICD10
• Structural Variation data of ICGC/PCAWG: 2,658 cancers across 38 tumour types
• Script to obtain human protein sequences by the gene symbols
• Command to download "Height" information from UKB with ukbfetch
• How to understand Instance and Array in UKB phenotype data
• KGML to SBML, BioPax, Sif (XGMML) or PSI-MI
• Roadmap Epigenomics Project Sample Amalgamation of Same Tissue?
• meta-analysis to multiple RNA-seq differential studies
• Method to Check Fastq Completeness after Fastq-dump
• bcftools merge 1021 individual vcf files
• Slurm, Son of Grid Engine, Mesos, and Hadoop YARN vs HTCondor and Torque
• Pros and cons to do biomedical research in pharmaceutical company
• Hg19 regions for Intergenic, Promoters, Enhancer, Exon, Intron, 5-UTR, 3-UTR and so on
• Zn binding sites and active site location in conserved domain database (CDD)
• Script to download fasta seqeuences for FGF1 to FGF12
• How to decrease the number of candidate TFs binding to gene promoter region
• Toxicity genes in metagenome RNA-seq data
• Handbooks for Bioinformatics Ninjas
• RNA-seq data including mixture samples like human, virus, bacterials
• Standard pipeline for drug target discovery and identification
• GTF annotation for Staphylococcus aureus
• Pan-cancer dataset of GENIE control data download and sharing
• Limitation of UKBB genotyping/sequencing data in drug target identificantion
• a gene become a drug target
• benefit of transfering hg19 vcf to hg38 vcf
• novel approaches to the functional assessment of genomic and/or epigenomic variants
• Linux sort P-values with scientific notation
• How to identify similar scientists based on published abstracts
• Detecting copy number variants from whole-exome sequencing data
• How to do data cleaning for VCF genetic file
• Phylogenetic tree with 0,1 matrix as the input?
• How to identify Transcript Factors (TF) binding to my target sequence
• lncRNA and mRNA regulation network database
• Hapmap3 in hg19/GRCh37 plink format PED and MAP

[ATpoint]

At this point I believe OP is a bot to troll users who actually make contributions here by shotguning these embarrassing do-my-work posts without ever making any contribution.